Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability

BACKGROUND: Elucidating the molecular mechanisms by which tumors become resistant to Herceptin is critical for the treatment of Her2-overexpressed metastatic breast cancer. METHODS: To further understand Herceptin resistance mechanisms at the molecular level, we used comparative proteome approaches...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Kang, Se Hun, Kang, Keon Wook, Kim, Kyung-Hee, Kwon, Bumi, Kim, Seok-Ki, Lee, Ho-Young, Kong, Sun-Young, Lee, Eun Sook, Jang, Sang-Geun, Yoo, Byong Chul
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2008
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2567332/
https://ncbi.nlm.nih.gov/pubmed/18834540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-8-286
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg